李健强,刘金石,陈奇勋.可切除非小细胞肺癌患者ABO血型与预后相关性[J].肿瘤学杂志,2019,25(5):409-412.
可切除非小细胞肺癌患者ABO血型与预后相关性
Association Between ABO Blood Types and Prognosis in Patients with Resected Non?鄄small Cell Lung Cancer
投稿时间:2018-12-07  
DOI:10.11735/j.issn.1671-170X.2019.05.B006
中文关键词:  ABO血型  肺癌  预后
英文关键词:ABO blood types  lung cancer  prognosis
基金项目:
作者单位
李健强 浙江省肿瘤医院 
刘金石 浙江省肿瘤医院 
陈奇勋 浙江省肿瘤医院 
摘要点击次数: 1952
全文下载次数: 295
中文摘要:
      摘 要:[目的] 探讨可切除的非小细胞肺癌ABO血型与预后之间的相关性。[方法] 回顾性分析2009年1月至2010年12月行肺癌根治术的非小细胞肺癌患者274例,收集包括血型在内的临床资料并进行生存随访。比较各血型之间5年生存率,并采用Cox比例风险模型进行单因素及多因素生存分析。[结果] O型患者的5年生存率分别为70.1%,A型为67.2%,B型为39.7%,AB型为56%。与非O型患者相比,O型患者5年生存率更高(P=0.002)。多因素分析提示年龄、病理分期,病理分型以及血型为独立的预后因素。[结论] ABO血型与可切除的非小细胞肺癌预后具有相关性,可作为一种独立的预后因素。
英文摘要:
      Abstract:[Objective] To explore the association between the ABO blood types and the prognosis in patients with resectabled non-small cell lung cancer(NSCLC). [Methods] Clinical data of 274 patients with resectable NSCLC admitted from January 2009 to December 2010 were analyzed retrospectively. The five-year overall survival rates(OS) were compared among patients with various blood types. A Cox proportional hazard model was used for the univariate and multivariate survival analyses. [Results] The 5-year overall survival rates were 70.1% for blood O group,67.2% for blood A group,39.7% for blood B group and 56% for blood AB group,respectively. The OS rate of patients with blood O type was higher than those of non-O type patients(P=0.002). Multivariate analysis showed that ABO blood types,age,pathological type and stage were independent prognostic factors for patients with resectable NSCLC. [Conclusion] The ABO blood group is related to the prognosis of patients with resectable NSCLC.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器